Propionyl CoA carboxylase (PCC) is a biotin-dependent mitochondrial enzyme that catalyzes the conversion of propionyl CoA to Dmethylmalonyl CoA. PCC consists of two heterologous subunits, α PCC and β PCC, which are encoded by the nuclear PCCA and PCCB genes, respectively. Deficiency of PCC results in a metabolic disorder, propionic acidemia, which is sufficiently severe to cause neonatal death. We have purified three PCCs containing pathogenic mutations in the β subunit (R165W, E168K, and R410W) and one PCCB polymorphism (A497V) to homogeneity in order to elucidate the potential structural and functional effects of these substitutions. We observed no significant difference in K M values for propionyl CoA between wild type and the variant enzymes, which indicated that these substitutions had no effect on the affinity of the enzyme for this substrate. Furthermore, the kinetic studies indicated that the mutation R410W was not involved in propionyl CoA binding in contrast to a previous report. The three mutant PCCs had half the catalytic efficiency of wild type PCC as judged by the k cat /K M ratios. No significant differences have been observed in molecular mass or secondary structure among these enzymes. However, the variant PCCs were less thermostable than the wild type. Following incubation at 47 o C, blue native PAGE revealed a lower oligomeric form (α 2 β 2 ) in the three mutants not detectable in wild type and the polymorphism. Interestingly, the lower oligomeric form was also observed in the corresponding crude E. coli extracts. The data and the structural analyses using a β PCC homology model indicate that the pathogenic nature of these mutations is more likely due to the lack of assembly rather than any disruption of the catalytic process. The strong favorable effect of the co-expressed chaperone proteins on PCC folding, assembly, and activity suggest that propionic acidemia may be amenable to chaperone therapy.
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Four different biotin-dependent carboxylases are known to play a central role in mammalian metabolic pathways, such as oxidation of odd-chain fatty acids, catabolism of branched amino acids, fatty acid synthesis and gluconeogenesis. One of these is propionyl CoA carboxylase (PCC, EC 6.4.1.3), which catalyzes the conversion of propionyl CoA to Dmethylmalonyl CoA in the mitochondrial matrix (1) . This enzyme consists of two nonidentical subunits, α and β, encoded by two different nuclear genes, designated PCCA and PCCB, respectively. Structural studies of the human enzyme have indicated that α PCC is 72 kDa in size while β PCC is 54 kDa. Overall, PCC has an α 6 β 6 structure (1,2). Mutations in either gene result in an autosomal recessive disease, propionic acidemia (PA: MIM 606054), which usually presents as a life-threatening ketoacidosis in the neonatal period with protein intolerance, vomiting, failure to thrive, lethargy, and profound metabolic acidosis symptoms. This disease can result in mental retardation and can be sufficiently severe to cause neonatal death (1) .
The cDNAs for α and β subunits have been cloned (Accession No. X14608 and X73424, respectively) and the structure of the genes has been elucidated (3) (4) (5) (6) (7) . With the sequence information available, it has been possible to identify mutations from PA patients (8) (9) (10) , and many new mutations have been found recently in different ethnic groups (11, 12) . Currently, approximately 52 and 53 mutations have been reported in the PCCA and PCCB genes, respectively (for a continuously updated list of all reported PCC mutations see our website at http://www.uchsc.edu/cbs/pcc/pccmain.htm). However, how these mutations affect the enzyme has not yet been established and how each mutation accounts for the patients' phenotype is difficult to determine since most of the PA patients are compound heterozygotes. This poor correlation between genotype and phenotype presents a problem in understanding this disease. Our interest is in elucidating the structural and functional consequences of mutations.
Since PCC has been expressed in our laboratory in a chaperone-assisted bacterial expression system (13) , several other studies have been carried out employing different expression systems and using crude cell extracts to address the effect of variations on stability and/or activity of the enzyme. A large number of PCCB mutations have been studied in the bacterial expression system (14) (15) (16) , and in a SV40-transformed fibroblast expression system (17, 18) . In addition, the effect of some PCCB mutations on the α-β heteromeric and β-β homomeric subunit assembly has been studied by a mammalian twohybrid expression system (19, 20) .
In our previous expression study (15) , we identified PCCB mutants (R165W, E168K, D178H, P228L, and R410W) that are PCC activity deficient in patient-derived fibroblasts but were found to be capable of expressing wild-type level PCC activity when assembled in our chaperoneassisted E. coli expression system. This result indicated that these mutations exert their pathogenic effect due to an inability to assemble correctly in patients' cells. In this paper, three mutations from this group, R165W, E168K, and R410W, have been chosen for verifying this assumption. The interspecies alignment of the βPCC subunit from different organisms shows that the residues affected by the patient-derived mutations are completely conserved in all homologous proteins studied (18) , suggesting their critical roles in proper protein function and structure (14, 15, 18) . R410W, which was said to be in the putative propionyl CoA binding site (21) , appears to be the most common disease-causing mutation in Japan (3, 8) . E168K, an allele prevalent in the Spanish and Latin American populations (6) , was associated with a broad spectrum of clinical manifestation in patients, ranging from severe to mild in both the homozygous and compound heterozygous conditions.
Crystal structure of fully assembled PCC is not available as yet. Over 20 years ago, Haase and coworkers have suggested, based on electron micrographs of PCC from Mycobacterium smegmatis (2,22) that six spherical α subunits on the periphery are attached to a large central hexameric core (β 6 ). Recently, crystal structures of Propionibacterium shermanii transcarboxylase 12S hexameric subunit (TC-12S) (23) and of Streptomyces coelicor βPCC (scPCC) were reported (24) . In both cases the β subunits, in the absence of α-subunits, form homohexamers (β 6 ).
The R165W mutation is close to the position of E168K. The structural analysis with a β PCC homology model indicated that R165 and E168 form a salt bridge with each other, and contribute to a local hydrogen-bonding network (23) . A497V was found to result in some improved characteristics in enzymatic catalysis (15) . It is relatively frequent among Spanish patients and was previously thought to be due to a single nucleotide polymorphism (6, 10, 15, 20) . Here, we present results using our bacterial expression system from which we can obtain ample quantities of PCC enzyme by successfully purifying mutant forms of PCC to homogeneity in order to define biochemical and structural properties of the mutant proteins.
MATERIALS AND METHODS

Materials
-Protogel acrylamide solution was acquired from National Diagnostics (Atlanta, GA). [ 14 C]-NaHCO 3 was purchased from Perkin Elmer Life Sciences (Boston, MA). Unless otherwise noted, all other chemicals were purchased from Sigma (St. Louis, MO).
Purification of recombinant human PCC enzymes from E. coli -Construction of the pPCCAB expression plasmid carrying both PCCA and PCCB sequences was described previously (13) . Derivatives of this expression construct containing the desired mutations, the conditions for the growth of bacterial cultures, cell harvesting, and preparation of the cell lysate were described previously (14, 15) . Cell debris and insoluble material were removed by centrifugation for 10 min at 5,000 × g at 4 o C and the supernatant fractions were further centrifuged for 35 min at 40,000 × g at 4 o C. The final supernatant thus generated was labeled crude extract.
Bacterial crude extracts were loaded onto a DEAE DE 52 column (5 × 12.5 cm) (Whatman) previously equilibrated with 10 mM potassium phosphate, pH 7.0. The column was washed with 10 mM potassium phosphate, pH 6.5, followed by 30 mM potassium phosphate, pH 6.5. PCC was eluted with 70 mM potassium phosphate, pH 6.5. The eluate was concentrated on Amicon using XM50 membranes (Millipore) and then adjusted with 10 × PBS buffer to a final concentration of 1 × PBS solution. This solution was loaded onto a monomeric avidin column (2.5 × 10 cm) (Pierce) previously equilibrated with PBS, pH 7.4. Recombinant PCC was incubated on the affinity column for 30 min and then eluted with 0.5 mM biotin in PBS, pH 7.4 after washing with PBS, pH 7.4. The protein was concentrated on Amicon with XM50 membranes to approximately 1-2 ml, and loaded onto a HR Sephacryl TM S-400 sizeexclusion column (1.5 × 95 cm) (AmershamPharmacia-Biotech). One main protein peak was collected. There was a small but much broader peak after this main peak in some of the variants containing primarily free α subunit. The purity of the preparations was > 95% as judged by SDS-PAGE. The proteins were then stored at a final concentration of 5-10 mg/ml in 10 mM potassium phosphate, pH 6.5 or PBS, pH 7.4 at -80 o C. Protein and enzyme assays -PCC activity was assayed as described previously with some modification (25) . The reaction mixture contained 50 mM Tris-HCl, pH 8.0, 2 mM ATP, 125 mM KCl, 10 mM MgCl 2 , 3 mM propionyl CoA, 0.5 mg/ml BSA, PCC enzyme (~10 µg of crude extract or 0.1 µg of purified PCC), and 10 mM [
14 C]-bicarbonate (specific activity 2 µCi/µmol) in a final volume of 50 µl, and incubated at 37 o C for 2 min. The reaction was terminated by adding 50 µl of 10% TCA. The mixture was centrifuged at 13,000 × g for 5 min and 50 µl of supernatant was dried in a scintillation vial in a heating block at 80 o C for 50 min. The dry residue was dissolved in 0.15 ml of H 2 O and 4 ml of OPTI-Fluor scintillation fluid (Packard Bioscience) was added. The samples were counted in Beckman LS 3801 scintillation counter. A blank containing the assay mixture without propionyl CoA was subtracted. Protein was determined by the Lowry method using a BSA standard (26 
using Origin 6.1 software (OriginLab Corporation, Northampton, MA).
Protein gel electrophoresis and Western blotting -Denatured proteins were separated by SDS-PAGE (27) using a 9% separating gel with a 4% stacking gel. Blue Native Polyacrylamide Gels (BN-PAGE) were prepared as described previously (28, 29) with some modification. Samples were loaded onto and run through a 5-13 % gradient polyacrylamide gel with a 4% stacking gel. Electrophoresis was carried out at 4
o C for about 6-7 hours. A high molecular weight calibration kit for electrophoresis (Amersham Biosciences) was used as the protein standard for BN-PAGE. The gels were stained with Simple Blue (Invitrogen, Carlsbad, CA). Western blotting transfer and detection conditions were as described previously (14) . The PCC antiserum was affinitypurified according to the method of Smith and Fisher (30).
Far UV circular dichroism -Circular dichroism spectra were determined with a Jasco J-810 spectropolarimeter (Jasco Inc.) at 4 o C using a fused quartz cuvette with 1 mm path length from 200 nm to 260 nm. Enzyme samples were at concentrations of 0.4-0.5 mg/ml in 10 mM potassium phosphate, pH 6.5. Data were collected at 0.2 nm increments. The results are expressed as the mean residue ellipticity, [θ] MRE (deg.cm 2 .dmol -1 ).
[
where [θ] obs is the observed ellipticity in millidegrees, [P] is the molar concentration of protein (αβ dimer), n is the number of residues per mol of protein molecule (αβ dimer), and l is the path length in centimeters. The percentages of α-helix and β-sheet were calculated using a prediction program, K2D algorithm (31, 32) . Thermal denaturation experiments were carried out using a Peltier IR cell temperature controller and monitoring the CD changes at 222 nm with the changing temperature. The scans were conducted with protein at about 0.5 mg/ml in 10 mM potassium phosphate, pH 6.5, and the temperature was increased at a ramping rate of 1°C/min from 20 o C to 90 o C. The data was analyzed according to Pace and Scholtz (33) .
HPLC analytical size-exclusion chromatography -HPLC analytical size-exclusion chromatography was performed on a Bio sep-SEC-S 400 size column (300 × 7.8 mm, Phenomenex) using a Beckman Gold HPLC system with the following mobile phase: PBS, pH 7.4 at a flow rate of 1 ml/min. The column was calibrated using the protein standards purchased from Bio-Rad.
Thermostability -Thermostability studies of the variant PCCs were carried out in two different ways. In the first case, enzymes (0.01 mg/ml) were incubated at 37 o C and small aliquots were removed at specific time intervals for activity assays. In the second case, enzymes (0.5 mg/ml) were incubated at three temperatures, 27 o C, 37 o C and 47 o C for 30 min. At the end of the incubation, samples were taken for PCC activity assay and a 6.5 µg aliquot was applied to BN-PAGE. The gels were stained with Simple Blue (Invitrogen).
Molecular modeling -Sequence alignments of human β PCC, five Mycobacterium β PCC from the NCBI database, TC-12S and scPCC show similar degrees of sequence conservation of ~50-70% over the entire polypeptide chain, strongly suggesting similar structures. Additionally, the individual segments that include the mutations are totally conserved amongst all four sequences. Specifically, these segments are in human β PCC residues 163-169 G-A-R-I-Q-E-G, residues 407-410 G-I-I-R and 496-497 A-A. Further, the TC-12S crystal structure that was determined first was used to solve the scPCC crystal structure.
A homology model of the PCC β 6 hexamer was constructed using the TC-12S crystal structure (PDB identifier 1ON3) (23) as a template and the InsightII software package (MSI). The amino acid substitutions for the mutations and polymorphism were modeled using O (34) and molecular figures prepared using Molscript (35) and Raster3D (36) .
RESULTS
Expression and purification of the wild type and variant PCCs. The wild type and variant forms of PCC were overexpressed using our previously described E. coli expression system (13) and were purified to near homogeneity as described under Materials and Methods (Fig.1) . With the exception of the enzyme containing the A497V polymorphism, all of the PCC variants exhibited significantly reduced yield, typically 25% of that obtained for wild-type PCC ( Table 1) . The relative activities of the variant enzymes compared to the wild type greatly improved after purification.
The A497V polymorphism demonstrated 30% higher specific activity than the wild-type enzyme, whereas the three mutants had comparatively lower specific activity, about 30-40 % of wild-type PCC.
Kinetic properties of the variant PCCs. The steady state kinetic constants of the variants compared with those of wild-type PCC are shown in Table 2 . We did not observe a significant difference in the K M values for propionyl CoA among these enzymes. Although the A497V polymorphism had a higher V max value compared to the wild-type enzyme, the catalytic efficiency of this polymorphism was not changed based on the k cat /K M ratios. On the other hand, the V max and the catalytic efficiency of the three mutants were reduced to about 50% of wild-type PCC.
Structural studies of the variant PCCs. The next step in our characterization of the variant enzymes was to look for changes in structure of these proteins. Initial structural studies were carried out by measurement of the far ultraviolet circular dichroism spectra, which are shown in Fig. 2 . The spectra of the mutant variant PCCs were quite similar to that of wild type. Based on statistical t-tests, there were no significant differences in either α helical content or β sheet content between the variants and wild type, which were on average about 29% and 18%, respectively (Table 3) . These results suggest that the substitutions have no significant effect on the secondary structure of mutant PCC proteins.
We utilized an HPLC size exclusion chromatography to study the quaternary structure of the PCC holoenzymes and the possible effect of Assembly and stability of the mutant PCCs. We performed native PAGE (25) in order to further confirm the molecular masses and assess the integrity of these polypeptides. The mutants and wild type PCCs behaved very differently when the gel was running at room temperature instead of at 4 o C. Wild type and A497V variant enzymes produced a distinct band, while the three mutants were smeared, suggesting that the quaternary structure of these mutants was somehow disturbed (data not shown).
We wondered if there is a possibility that temperature affects not only the PCC activity of the mutant enzymes, but their oligomeric status as well. However, a standard native gel and an HPLC analytical size exclusion chromatography are not very useful to test this possibility because of the large size of PCC of about 800 kDa. PCC barely migrates even into 5 % gel and the resolution on an HPLC exclusion column is not very high either. Thus, we employed blue native polyacrylamide gel electrophoresis (BN-PAGE) (28, 29) to examine the oligomeric status of the enzymes following their exposure to three different temperatures (27 o C, 37 o C, and 47 o C). Enzyme samples were analyzed by BN-PAGE after being incubated for 30 min and enzyme activity of each of the treated samples was assayed as well (Fig 5) . BN-PAGE is a "change shift" method developed for isolation of native membrane protein complexes from biological membranes that also separates both acidic and basic water-soluble proteins at a fixed pH of 7.5. It provides an analytical method for the determination of molecular mass and oligomeric state of nondissociated complexes, of subunit composition, and of degree of purity and for the detection of subcomplexes (29) .
Incubation at three temperatures did not result in any loss of activity of wild-type PCC, and the polymorphic A497V lost 40% of its activity only at the highest temperature of 47 o C. At the same time, the three mutants were much more sensitive to the increases in temperature. They lost about 30% and 85% of activities at 37 o C and 47 o C, respectively, consistent with our thermostability study mentioned above. BN-PAGE (Fig.5) shows that wild type PCC contains two main bands, very close to each other and migrating slower than the largest protein marker of 670 kDa. At the top of the gel, there are two weak bands, which are probably the aggregated forms of PCC. The the βPCC substitutions on oligomeric assembly. With the purified forms of enzymes, variant and wild-type PCCs produced only one sharp protein peak and there was no significant difference in protein molecular mass between these variants and wild-type, which was about 800 kDa (Table 3) , consistent with the α 6 β 6 structure. This result was similar to our previous findings using a HR Sephacryl S-300 size exclusion column (15) . Altogether, none of the substitutions caused any detectable structure changes on PCC oligomers.
Thermostability of the variant PCCs. Another tool we employed to compare the properties of the wild type and variant enzymes were thermostability studies using different approaches. The enzymes were first studied by incubating them at 37 o C for different time intervals followed by enzyme assays. By the end of the 40-minute incubation period, the activities of the variants decreased to about 30% of the initial activity compared to 70% for the wild type enzyme (Fig. 3) . The thermal stability of the variant enzymes was also assessed by following changes in the far UV CD signal with increasing temperature. From the thermal denaturation curves (Fig. 4) and the data analyzed by a two-state model, it is clear that wild type enzyme undergoes a cooperative two-state transition between the native and denatured states with a Tm of 57.6 o C (Table 3 ). The thermal denaturation profile of all PCC forms studied here are irreversible. The variant enzymes showed very similar Tm values when compared with wild-type enzyme (Table 3) . Thermal denaturation detected by far UV CD signal reflects changes in the secondary structure, specifically α helix, of the monomeric protein species. Hence, comparable Tm values observed in this work clearly indicated that the overall thermal denaturation of PCC happened to be independent of the individual point substitutions. However, the denaturation curves of the variant enzymes did not overlay with that of wild-type enzyme, indicating formation of some intermediate species in the thermal unfolding. These intermediates could possibly reflect (a) the presence of higher order aggregates with the mutant enzymes just before initiation of thermal unfolding (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) o C) and (b) formation of some lower oligomeric forms at higher temperatures (58-60 o C) with the mutant enzymes. Further studies in this connection were not possible due to irreversibility of thermal denaturation and precipitation of protein.
polymorphic variant of PCC, the A497V, shows almost the same bands as the wild type. The three mutant PCCs have one main band at the same position as the wild type with a weaker band below. The bands at the top of the gel, which we assume to be aggregates, are darker than those in the wild type lanes. There are no visible differences for each enzyme between the treatments of 27 o C and 37 o C. However, following the treatment at 47 o C, the oligomeric status of each protein has undergone some changes. Wild type and the polymorphism A497V show almost the same change while the three mutants appear to belong to another group. In the wild type and A497V lanes, the weaker bands below the main band became darker, especially in the A497V sample, and one or two new weak bands with a smaller molecular mass appeared. In contrast, the main band of the three mutants has lost a lot of its intensity and a new protein species with a molecular mass of ~330kDa appeared. When the mutant proteins were treated at 52 o C, they became cloudy and the proteins were trapped in the stacking gel (data not shown).
We were interested what was the subunit composition of the new 330kDa band. We isolated and analyzed this form of PCC by SDS-PAGE (Fig.5, bottom at right) . The ~330 kDa species from each of three mutants dissociated into two polypeptides co-migrating with the α and β subunits derived from the wild type. The ratio of densities of the two bands was about 1:1.
We wondered whether the 330-kDa species might be already detectable in crude cell extracts of E. coli containing the plasmids expressing the variants. The crude cell extracts were analyzed by BN-PAGE followed by Western blotting with affinity-purified anti-PCC antibody. A crude cell extract derived from E. coli containing only the chaperone, GroES and GroEL plasmid, was used as a negative control and a purified PCC protein as a positive control. Again, the ~330kDa band was observed in the crude extracts of the three mutants, while the wild type and the A497V did not show it (Fig 6) . This finding means that very likely the same PCC oligomer is formed either in E. coli cells containing the mutant PCCs or by heating the purified human recombinant mutant protein.
DISCUSSION PCC consists of heterogeneous subunits in an equal ratio (α 6 β 6 ). Mutations have been found in both subunits (10) . Prior studies have indicated that many mutations in PCCA result in the patient having little or no α PCC and β PCC, and that the existence of β subunit is dependent on the existence of α subunit (37, 38) . The opposite, however, is not true. Mutations in PCCB may result in variable amounts of β PCC or none at all, but α PCC remains stable in all cases.
In this paper, we chose three PCCB mutations in which immunoreactive protein was found, and that showed some residual enzyme activity in extracts of patient fibroblasts (15) . When we expressed these mutations in E. coli and assayed their PCC activity in crude extracts, they were found to be capable of expressing wild-type level activity when assembled in our chaperoneassisted expression system (15) . The three PCCB mutants (R165W, E168K, and R410W) demonstrated between 32 and 43% of wild-type enzyme activity after purification to homogeneity. In contrast, the polymorphic variant had nearly 140% of wild type activity. Our goal was to elucidate the potential structural and functional effects of these substitutions on the mutant enzymes and to verify our assumption that these PCCB mutations may result in some impairment of assembly but little effect on catalytic activity.
Is the catalytic activity affected by these mutations? We first investigated whether the lower activity of the mutants was due to a decreased affinity of the mutant PCCs for the substrate. Based on the study of interallelic complementation and sequence homology with the Propionibacterium shermanii transcarboxylase 12S subunit (TC12S), it was assumed that the propionyl CoA binding site was located in the β subunit and, furthermore, that mutation R410W was part of the propionyl CoA binding site (21) . Surprisingly, our steady state kinetic studies did not show any significant difference in K M values for propionyl CoA among these variants and the wild-type enzyme (Table 2) , which indicated that these amino acids may not be involved in the propionyl CoA binding site and that the Arg410 residue was not responsible for propionyl CoA binding, as presumed previously. The TC12S subunit whose crystal structure has been resolved recently (23) , carries out a biotin-dependent carboxyl transfer reaction similar to that catalyzed by PCC and shares 40% sequence identity with the β subunit of PCC (5, 23, 39) . The TC12S based homology model of the β PCC subunit predicts a conserved protein fold, hexamer structure, and active site.
The conserved PCC β R410 corresponds to TC12S R387 and is located far from the MMCoA binding site, consistent with our kinetic study; the shortest distance between R410 and MMCoA is 14 Ǻ, through the body of the protein (Fig 7) (23) .
Besides no differences in the affinities for the substrate, our purified mutant PCCs had catalytic efficiencies, k cat /K M , reduced to only about half the value of the wild-type, which does not explain the low residual PCC activity found in patient-derived fibroblasts and the severe disease caused by the mutations studied here. Do these mutations affect the secondary structure, protein stability or dodecamer assembly? Previous work has indicated that the changes in the α/β subunit ratio of PCC is the result of unsuccessful interaction of the β subunit with the α subunit (38) . In the previous expression studies, some PCCB mutations were shown to cause complete instability of the β subunit, while other PCCB mutations, such as R165W and E168K, showed an increased α/β subunit ratio compared to wild-type due to the presence of free α subunits (15) . The purified mutant enzymes did not show any measurable differences in their secondary structures using the far UV CD approach ( Fig. 2 and Table 3 ). Size exclusion HPLC showed that the mutant PCCs had a molecular mass around 800 kDa, consistent with the α 6 β 6 oligomeric structure. Furthermore, blue native PAGE further confirmed the molecular masses and assessed the integrity of these polypeptides (Fig. 5 bottom) . These data suggested that all the enzymes had similar quaternary structures. We noticed, however, that the activity of the mutant enzymes decreased significantly following incubation at 37°C or 47 o C (see Figs. 3 and 5 top). In addition to the changes in activity, the oligomeric status of these mutants changed when the enzymes were exposed to increased temperatures (Fig. 5, bottom) . These results implied a reduced stability of the assembled mutant enzymes, and the reduced stability was likely due to weak or improper interactions between the mutant β PCC subunits or between the α PCC and mutant β PCC compared to wild type subunits.
In addition, a new oligomeric form of PCC of about 330 kDa appeared after the mutant PCCs had been exposed to increased temperatures (Fig 5,  bottom) . Moreover, the same 330kDa form was detected in the corresponding crude E. coli extracts (Fig. 6 ). Based on a subsequent SDS-PAGE analysis (Fig.5, bottom, lane 1) , this oligomeric form appears to be a tetramer of α 2 β 2 structure. It is not unreasonable to suggest that PCC assembly sequence involves formation of tetramers, α 2 β 2 and that the enzyme is, in fact, a trimer of tetramers. This is similar to the homologous TC12S hexamer, which dissociates into dimers, and thus is a trimer of dimers (40) (41) (42) . Thus, the PCC mutations likely weaken the interactions in the context of the α 6 β 6 dodecamer rather than in an isolated β 6 hexamer.
The increased α/β subunit ratio (15) and the small PCC form observed in crude cell extracts of the mutants (Fig. 6 ) indicated that smaller cross reactive forms existed and that they were the result of the mutations. Second, the resolution of the HPLC column was not high enough to separate the different oligomeric PCC forms as efficiently as the BN-PAGE because of the extremely high molecular mass of PCC. Thus, these mutations do result in some misfolding and/or unassembled mutant protein produced during synthesis of recombinant mutant PCC. Even the assembled mutant PCC dodecamers disassociate at higher temperatures accompanied by loss of activity. The lower specific activity of the mutants and the lower V max observed in kinetic studies compared with wild-type may be the side effect of the dodecamer instability rather than due to any impairment of catalytic ability.
β PCC homology modeling. Analysis of the β PCC homology model provides explanations for the possible effects of the variants on quaternary structure. R165, E168, R410, and A497 are all conserved in Mycobacterium β PCC, TC12S and scPCC bolstering use of the homology model for structural interpretations. Significance of β 6 is further provided by the electron micrograph of Mycobacterium smegmatis PCC (2) that suggests a central core of β 6 surrounded by six α subunits. There is no evidence of formation of β 6 in our system where both types of subunits are expressed in stoichiometric amounts. The mutants and the polymorphism alter residues, which are located near the surface of the monomeric protein fold, and none are predicted to cause global protein misfolding or instability. Instead, the three mutants are likely to have local conformational differences relative to wild type while the polymorphism is predicted to cause little or no local conformational change.
For example, within the same β monomer, R165 and E168 form a salt bridge with each other, and contribute to a local hydrogenbonding network involving D105 and C90 which serves to tether two surface loops and appears to be important for local structure (Figure 7, 8) . It should be mentioned that D105 is totally conserved residue amongst all four sequences. The loop containing R165 and E168 is also adjacent to the opposing β monomer in the dimer pair. Since the R165W and E168K mutants are predicted to disrupt the local hydrogen-bonding network, the absence of these interactions is likely to result in a local conformational change. This, in turn, could alter the intermolecular interface in the β dimer pair, and consequently hexamer / dodecamer formation and / or stability.
R410W is expected to have a similar effect. R410 is also located at the β dimer interface, albeit distant from the active site: it hydrogen bonds across the dimer interface with S254 in the opposing β monomer. It should be mentioned that S254 is totally conserved residue amongst all four sequences.
The R410W mutant introduces sterically unfavorable short contacts that require a change in local main chain conformation for removal. This local structural change at the β dimer interface would likely also alter hexamer / dodecamer formation and / or stability.
However, in absence of crystal structure of α 6 β 6 dodecamer of PCC per se, the arguments above provide the best clue as to how these mutations could affect the enzyme. The sequence of events in the overall assembly of α 6 β 6 PCC from individual α and β peptide syntheses remains an open question although there is evidence for α 2 β 2 tetramer in the degradation process and thus the α 2 β 2 tetrameric species may be involved in the overall assembly of α 6 β 6 PCC.
Some mutant PCCs respond strongly to molecular chaperones. It was reported that by using the mammalian two-hybrid system, the mutations R165W and E168K resulted in a 40% reduction in α-β and in β-β subunit assembly. Lowering the temperature from 37 o C to 27 o C, however, allowed the rescue of assembly of both mutants to normal levels (19, 20) . Temperatures lower than the physiological one have a positive effect on protein folding, mimicking the role displayed by molecular chaperones (43, 44) . In our expression system, PCC is expressed in the presence of the bacterial chaperone proteins, GroEL and GroES (13) , which are homologous to the eukaryotic chaperones, hsp60 and hsp10. Chaperone proteins assist polypeptide folding by unfolding nonfunctional conformations, followed by reinitiating the folding process in order to escape protein degradation (45) . Co-expression of human polypeptides with bacterial chaperone proteins has been shown to correct the misfolding of some mutant forms of phenylalanine hydroxylase (46) . Misfolded proteins are typically destined for proteolytic degradation (20) . Missense mutations not situated in the active site or cofactor binding site may have an effect on protein stability by producing nonfunctional conformations that lead to degradation or aggregation (44) . The levels of chaperone proteins in our expression system do not mimic those levels found in eukaryotic cells because we have overexpressed GroES and GroEL. Consequently, the residual activity of our purified proteins is higher than that seen in vivo. Therefore, we suggest that these mutant PCCs can be folded into a conformation and can be assembled into a holoenzyme, which restores some of their wild type activity with the help of chaperone proteins. However, these mutant polypeptides still maintain some degree of misfolding, resulting in decreased stability and enzymatic activity. Further tests in vivo using pulse chase experiments may help elucidate the level of mutant protein production in patient cells and the turnover rate of these subunits. How the chaperones affect the folding and/or assembly of PCC and whether molecular or chemical chaperones can rescue these mutant proteins in vivo are a subject of ongoing studies and these approaches may provide a way to help the patients who suffer from propionic acidemia due to these or similar mutations.
The variant A497V has always been seen in cis together with either the mutation R165Q or the V217K/218del2 on Spanish mutant alleles (18, 20) . We were unsure how this variant contributed to the pathogenesis of PA. Purification of A497V, followed by thermostability studies, indicated that the A497V-containing enzyme was less stable than wild type PCC. On the other hand, this substitution had no effect on substrate binding, catalytic efficiency, or oligomeric assembly. In contrast to the three mutations, A497 is located at Genotype -phenotype correlations. Genotypephenotype inconsistencies exist for some of these mutations. It is unclear why patients with the same allelic mutations have different clinical symptoms. It has been speculated that environmental and genetic factors (such as gene modifiers or sequence alterations in other chaperonin genes that mildly impair folding) may combine to modulate the outcome of clinical disease (44) . Although we have not investigated sequence polymorphisms among the chaperone proteins in these patients, the increased enzymatic activity seen in our bacterial expression system suggests that an overabundance of chaperone proteins may produce significantly higher enzymatic activities. These higher activities, in turn, may lead to milder clinical symptoms. The phenotypic variability between patients, therefore, may be a consequence of PCC mutations in addition to polymorphisms in chaperone proteins. the trimer interface, i.e. between dimer pairs, and while it is a conserved residue, it is in a less conserved local environment. Compared with the mutations studied here, the larger side chain of the A497V variant introduces short contacts, which are expected to be easily accommodated by little or no change in local protein conformation, and thus little or no change in quaternary structure/stability. Our experiments point to some small local conformational changes but no significant impact on the oligomeric status and support the notion that A497V is a single nucleotide polymorphism as concluded from previous work on interactions between α-β or β-β subunits (19, 20) or from PCC activity measurements (15) . The potential modifying effect of A497V on R165Q has been investigated in crude extract of SV40-transformed fibroblasts, and no measurable effects were seen (18) . The abbreviations used are: BN-PAGE, blue native polyacrylamide gel electrophoresis; BSA, bovine serum albumin; CD, circular dichroism; PA, propionic acidemia; PBS, phosphate buffered saline; PCC, propionyl CoA carboxylase; scPCC, Streptomyces coelicor PCC; SDS, sodium dodecyl sulfate; TCA, trichloroacetic acid; MMCoA, methylmalonyl-CoA; TC12S, transcarboxylase 12S subunit. Fig. 1 . SDS-PAGE analysis of purified wild-type and mutant PCCs. Proteins, 5 µg each, were subjected to 9% SDS-PAGE. Fig. 2 . Circular dichroism (CD) spectra of wild type and mutant PCCs. The protein concentrations were 0.5 mg/ml and the path length of cell was 1 mm. Buffer for CD determination was 10 mM potassium phosphate, pH 6.5 and determinations were performed at 4 o C with 3-6 times for each enzyme. Fig. 3 . Thermal stability of wild type and variant PCCs. The PCCs (0.01 mg/ml) were incubated in PBS, pH 7.4 and 4% glycerol at 37 o C. Samples were removed at the times indicated and enzyme activity was determined. Each assay was repeated 4-7 times and the error bars indicate the standard error. Fig. 4 . Thermal denaturation of wild type and variant PCCs monitored by CD changes at 220 nm. The protein concentrations were 0.5 mg/ml and the path length of cell was 1 mm. Buffer for CD determination is 10 mM potassium phosphate, pH 6.5 and determinations were repeated 3 times. o C for 30 min, respectively. M stands for the molecular mass marker. In order to determine the composition of the new ~330 kDa band that has appeared in the mutant lanes after incubation at 47 o C, the gel piece containing this band was cut out, boiled in SDS gel sample buffer for 5 min and inserted into a well a 9% SDS gel. Lane 1 and 2 (bottom right) show the analysis of the 330-kDa band and wild type enzyme, respectively. Fig. 6 . BN-PAGE and Western Blot analysis of the oligomeric status of wild type and variant PCCs in the crude extract of E. coli. The proteins, 50 µg, were subjected to BN-PAGE and PCC was detected after blotting with anti-PCC antibody. Lanes 1 to 7 are WT, A497V, R165W, E168K, R410W, GroESL, and purified PCC, respectively. Lane M is the molecular mass marker. Fig. 7 . Homology model of β PCC. Two orthogonal views of the β 6 hexamer predicted to form part of the α 6 β 6 dodecamer. Monomers are shown as coil structures, with one dimer pair colored purple and cyan. The six MMCoA substrates (yellow ball-and-stick, as observed in the homologous TC-12S crystal structure) and the six biotin molecules (red ball-and-stick, as observed in the homologous scPCC crystal structure) are bound between monomers at the dimer interface. Mutation and polymorphism sites are shown for the purple and cyan dimer pair. R165W, E168K, and R410W (blue spheres) are located near the dimer interface, with the former two adjacent to the substrate binding site, while A497V (yellow sphere) is located near an inter-dimer (intra-trimer) interface. Fig. 8 . R165W and E168K mutants in the β PCC homology model. Left, R165 and E168 in wild-type β PCC participate in a hydrogen-bonding network (dashed lines), which includes C90 and D105. These interactions serve to tether two surface loops (thick purple coil). The loop containing R165 and E168 is adjacent to the opposing monomer (cyan) in the dimer pair, and flanks the binding site for the MMCoA substrate (thin ball-and-stick, from the TC-12S crystal structure); the biotin site (identified in the scPCC crystal structure) is further away. Right, R165W and E168K (green bonds and carbon atoms) in β PCC mutants are predicted to disrupt the local hydrogen-bonding network. 
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